Conduct Phase III CT: CDSCO panel tells Dr Reddy's Labs after noting Dutasteride linked with AEs like sexual impotence Dr. Divya Colin7 Jun 2024 6:13 PM ISTNew Delhi: Noting that the drug Dutasteride is associated with significant incidence of adverse events including sexual impotence the Subject Expert...
Justify dose and rationality: CDSCO Panel Tells Dr. Reddy's Lab on Sacubitril-Valsartan tablets 25 mg Dr. Divya Colin6 May 2024 6:00 PM ISTNew Delhi: Noting that the proposed protocol is insufficient to prove the clinical relevance of the lower strength of Sacubitril/Valsartan...
Dr Reddy's Laboratories gets CDSCO Panel Nod To Import and Market Toripalimab 240mg solution for infusion Dr. Divya Colin20 April 2024 6:00 PM ISTNew Delhi: Noting an unmet medical need for recurrent locally advanced/metastatic nasopharyngeal carcinoma (RM-NPC) in India, the Subject Expert...
Dr.Reddy's Labs gets CDSCO Panel Nod To Manufacture, Market anti-cancer drug Lenalidomide 20mg additional strength Dr. Divya Colin19 April 2024 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Labs has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Dr. Reddy's gets CDSCO panel Nod To market Omeprazole Delayed-release orally disintegrating tablets Dr. Divya Colin4 March 2024 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a go-ahead from the Subject Expert Committee (SEC) functional...
CDSCO Panel Rejects Dr Reddy's Proposal to Study FDC of Ketorolac plus Serratiopeptidase Capsules Dr. Divya Colin18 Feb 2024 6:00 PM ISTNew Delhi: Citing there is no rationality of the combination and significant benefits, the Subject Expert Committee (SEC) functional under the...
Add geographically distributed Govt sites: CDSCO Panel tells Dr Reddy's on antirheumatic drug Abatacept study Dr. Divya Colin3 Feb 2024 6:00 PM ISTNew Delhi: The drug major Dr Redyy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Determine efficacy of immunotherapy in PD-L1 negative and low patients: CDSCO Panel Tells Dr Reddy on Nivolumab Dr. Divya Colin20 Jan 2024 5:30 PM ISTNew Delhi: Based on the Phase I/III clinical trial protocol of the anti-cancer drug Nivolumab presented by the drug major Dr Reddy Laboratories, the...
Dr Reddys Labs arm, Coya Therapeutics ink pact for Amyotrophic Lateral Sclerosis therapy COYA 302 Ruchika Sharma7 Dec 2023 1:30 PM ISTDr Reddy's will make a USD 7.5 million upfront payment to Coya.
Dr. Reddy's Gets CDSCO Panel Nod to Study FDC Etoricoxib plus Thiocolchicoside for Export purpose Dr. Divya Colin1 Dec 2023 6:00 PM ISTNew Delhi: The drug major Dr Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Revise Phase III CT protocol of Olokizumab as a single-arm study: CDSCO Panel Tells Dr Reddys Dr. Divya Colin17 Oct 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Dr...
CDSCO Panel Rejects Dr. Reddy's Proposal For Ketorolac Tromethamine plus Serratiopeptidase FDC Dr. Divya Colin7 Aug 2023 6:00 PM ISTNew Delhi: Citing there is no rationality data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
